Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019

Anti-spike monoclonal antibodies emerged as effective early treatment of high-risk individuals with mild-to-moderate COVID-19. Although their clinical and safety outcomes have been reported, patient perspectives of these experimental therapies have not been evaluated. In this survey participated by...

Full description

Bibliographic Details
Main Authors: Raymund R Razonable MD, Ravindra Ganesh MBBS, MD, Rachel K Bishop RN, Tracy L Culbertson MSN, RN, Molly Destro Borgen MA, Michelle C Hedin MSN, RN, Laura H Hopkins RN, Tammy A Jackson RN, Jennifer J Larsen MSN, RN, Jennifer A Matoush APRN, MS, Darcie E Moehnke MAN, RN, Shelly M Olson MSN, RN, Kellie M Peterson RN, Jordan Rosedahl BS, Lindsey M Philpot PhD, MPH
Format: Article
Language:English
Published: SAGE Publishing 2022-06-01
Series:Journal of Patient Experience
Online Access:https://doi.org/10.1177/23743735221105673

Internet

https://doi.org/10.1177/23743735221105673

Similar Items